Arrowhead Pharmaceuticals Market Cap

Arrowhead Pharmaceuticals has a market cap or net worth of $1.42 billion as of April 17, 2025. Its market cap has decreased by -56.80% in one year.

Market Cap

1.42B

Enterprise Value

1.74B

1-Year Change

-56.80%

Ranking

#2074

Market Cap Chart

Since June 30, 2004, Arrowhead Pharmaceuticals's market cap has increased from $95.40M to $1.42B, an increase of 1,385.68%. That is a compound annual growth rate of 13.84%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2025	1.42B	-39.42%
Dec 31, 2024	2.34B	-28.84%
Dec 29, 2023	3.29B	-23.54%
Dec 30, 2022	4.30B	-37.84%
Dec 31, 2021	6.92B	-11.95%
Dec 31, 2020	7.86B	29.67%
Dec 31, 2019	6.06B	451.13%
Dec 31, 2018	1.10B	299.42%
Dec 29, 2017	275.20M	154.58%
Dec 30, 2016	108.10M	-70.48%
Dec 31, 2015	366.20M	-9.27%
Dec 31, 2014	403.60M	-3.88%
Dec 31, 2013	419.90M	1,153.43%
Dec 31, 2012	33.50M	-24.04%
Dec 30, 2011	44.10M	-31.42%
Dec 31, 2010	64.30M	93.09%
Dec 31, 2009	33.30M	-15.70%
Dec 31, 2008	39.50M	-72.93%
Dec 31, 2007	145.90M	-2.60%
Dec 29, 2006	149.80M	25.99%
Dec 30, 2005	118.90M	101.87%
Dec 31, 2004	58.90M	-38.26%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	754.27B
UnitedHealth Group	415.38B
Johnson & Johnson	379.48B
AbbVie	306.02B
Novo Nordisk	284.50B
Abbott Laboratories	227.16B
Novartis AG	209.93B
AstraZeneca	208.11B

Market Cap Rankings